Matinas BioPharma MTNB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | 9.18 | 2 | -55 | -1 | -28.56 | 3 |
| 2026Q1 | 7.5 | 3 | -48.93 | -2 | -29.37 | 6 |
| 2025Q4 | 8.79 | 5 | -33.87 | -2 | -22.62 | 7 |
| 2025Q3 | 28.35 | 6 | -21.68 | -2 | -14.51 | 10 |
| 2025Q2 | 13.35 | 8 | -75.22 | -5 | -44.72 | 11 |
| 2025Q1 | 7.8 | 6 | -23.9 | -2 | -13.42 | 12 |
| 2024Q4 | 7.65 | 8 | -72.17 | -8 | -50.77 | 13 |
| 2024Q3 | 53.1 | 16 | -24.51 | -4 | -19.02 | 21 |
| 2024Q2 | 118.73 | 19 | -33.98 | -6 | -26.01 | 24 |
| 2024Q1 | 203.25 | 15 | -34.46 | -6 | -26.05 | 20 |
| 2023Q4 | 162.15 | 19 | -25.07 | -5 | -19.36 | 25 |
| 2023Q3 | 97.5 | 23 | -23.74 | -6 | -18.98 | 30 |
| 2023Q2 | 270 | 28 | -20.04 | -6 | -16.77 | 34 |
| 2023Q1 | 352.5 | 33 | -15.92 | -6 | -13.27 | 38 |
| 2022Q4 | 375 | 37 | -9.66 | -4 | -7.87 | 45 |
| 2022Q3 | 477 | 39 | -13.41 | -5 | -10.93 | 48 |
| 2022Q2 | 592.5 | 43 | -13.09 | -6 | -10.95 | 52 |
| 2022Q1 | 603.3 | 48 | -11.94 | -6 | -10.21 | 56 |
| 2021Q4 | 757.5 | 52 | -12.1 | -7 | -10.44 | 61 |
| 2021Q3 | 975 | 58 | -11.29 | -7 | -9.98 | 67 |